1. Home
  2. PED vs SCLX Comparison

PED vs SCLX Comparison

Compare PED & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PED
  • SCLX
  • Stock Information
  • Founded
  • PED N/A
  • SCLX 2011
  • Country
  • PED United States
  • SCLX United States
  • Employees
  • PED N/A
  • SCLX N/A
  • Industry
  • PED Oil & Gas Production
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PED Energy
  • SCLX Health Care
  • Exchange
  • PED Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • PED 48.8M
  • SCLX 51.3M
  • IPO Year
  • PED N/A
  • SCLX N/A
  • Fundamental
  • Price
  • PED $0.56
  • SCLX $6.02
  • Analyst Decision
  • PED Strong Buy
  • SCLX Strong Buy
  • Analyst Count
  • PED 3
  • SCLX 4
  • Target Price
  • PED $1.83
  • SCLX $11.33
  • AVG Volume (30 Days)
  • PED 174.7K
  • SCLX 68.9K
  • Earning Date
  • PED 05-14-2025
  • SCLX 05-12-2025
  • Dividend Yield
  • PED N/A
  • SCLX N/A
  • EPS Growth
  • PED 921.21
  • SCLX N/A
  • EPS
  • PED 0.20
  • SCLX N/A
  • Revenue
  • PED $39,553,000.00
  • SCLX $56,590,000.00
  • Revenue This Year
  • PED $1.03
  • SCLX $115.30
  • Revenue Next Year
  • PED $68.58
  • SCLX $73.33
  • P/E Ratio
  • PED $2.81
  • SCLX N/A
  • Revenue Growth
  • PED 28.49
  • SCLX 21.07
  • 52 Week Low
  • PED $0.47
  • SCLX $5.80
  • 52 Week High
  • PED $1.10
  • SCLX $80.50
  • Technical
  • Relative Strength Index (RSI)
  • PED 35.50
  • SCLX 30.63
  • Support Level
  • PED $0.54
  • SCLX $6.13
  • Resistance Level
  • PED $0.58
  • SCLX $7.64
  • Average True Range (ATR)
  • PED 0.06
  • SCLX 1.42
  • MACD
  • PED -0.00
  • SCLX -0.21
  • Stochastic Oscillator
  • PED 34.09
  • SCLX 3.80

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: